side effects of glp-1 medication GI Adverse Glucagon-Like Peptide-1 Receptor Agonists Your guide to GLP-1 side

Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA

Moreover, the addition of finerenone to this combination therapy could potentially provide stronger cardiorenal protective benefits

3rd-party tested for accuracy

These medications are powerful tools for weight loss and blood sugar controlbut they can also cause some surprising changes in your menstrual cycle

Heres the catch: when your appetite goes down, its easy to accidentally underfuel

GLP-1 focused - useful for every body